They're drugs taken by one in seven Australians daily, but have harrowing side effects no one wants to talk about. Now the pharma watchdog is finally taking action - but for many it's already too late One in seven Australians take anti-depressant drug daily Product label must now include a harrowing side effect READ NOW: Experts hopeful they've solved mystery of baffling colon cancer By Olivia Day For Daily Mail Australia Published: 23:49 EDT, 3 June 2024 | Updated: 23:51 EDT, 3 June 2024 e-mail View comments Drug companies will be foreced to include warning labels on antidepressant packaging that the medication could cause long-lasting sexual dysfunction. The Therapeutic Goods Administration (TGA) will recognise that sexual dysfunction for those taking selective serotonin reuptake inhibitor medications (SSRI) could last for months or even years after the patient has stopped taking the drug.
The TGA has so far received 89 reports of sexual dysfunction with an SSRI or an SNRI in its adverse event database as well as four reports of sexual dysfunction that persisted after three men and one woman stopped the medication. However, the agency believes post-SSRI sexual dysfunction (PSSD) is underreported in Australia due to the hundreds of cases being recorded in Europe. The reports detail symptoms such as difficulty reaching orgasm, weakened orgasms, erectile dysfunction and reduced penile sensation, The Australian reported.
Drug companies will be required to list long-lasting sexu.
